Steve Schonfeld’s Insmed INSM Stock Holding History

Steve Schonfeld’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-18,100	Closed	-$1.32M	–	2195
2024 Q3	$1.32M	Buy	+18,100	New	+$1.34M	0.01%	1060

Other funds holding INSM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Steve Schonfeld's INSM Position: Q2 2026 in Review

Steve Schonfeld increased its Insmed (INSM) stake by 86% in Q2 2026, buying an estimated $5.85M and bringing the position to 104,378 shares worth $11.1M. The position accounts for 0.04% of the portfolio, ranked #390.

Steve Schonfeld first reported a position in INSM in Q2 2017 and has held it in 21 quarters since. 663 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

Steve Schonfeld held 104,378 shares of Insmed worth $11.1M as of Q2 2026.
Steve Schonfeld bought 48,322 Insmed shares in Q2 2026, an estimated $5.85M.
Insmed made up 0.04% of Steve Schonfeld's portfolio in Q2 2026, its #390 holding.
Steve Schonfeld first reported a position in Insmed in Q2 2017 and has held it in 21 quarters since.
663 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.